Compare NYAX & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NYAX | AXGN |
|---|---|---|
| Founded | 2005 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.5B |
| IPO Year | 2022 | 2013 |
| Metric | NYAX | AXGN |
|---|---|---|
| Price | $57.83 | $32.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $49.50 | $36.11 |
| AVG Volume (30 Days) | 11.1K | ★ 759.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $25.96 | $19.81 |
| Revenue Next Year | $19.69 | $16.31 |
| P/E Ratio | $89.78 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $32.38 | $9.22 |
| 52 Week High | $60.77 | $36.00 |
| Indicator | NYAX | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.66 | 52.08 |
| Support Level | $42.63 | $29.13 |
| Resistance Level | $60.77 | $34.70 |
| Average True Range (ATR) | 1.38 | 1.69 |
| MACD | 0.55 | 0.11 |
| Stochastic Oscillator | 97.03 | 72.16 |
Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.